What is the Impact Factor of Rare Disease and Orphan Drugs Journal?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Rare Disease and Orphan Drugs Journal is 1.90, ranking in quartile Q3 of Web of Science (ESCI).

Is Rare Disease and Orphan Drugs Journal indexed in Web of Science or Scopus?

Yes, Rare Disease and Orphan Drugs Journal is indexed in Web of Science (ESCI, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.385 (Q3) and an H-index of 7.

Who publishes Rare Disease and Orphan Drugs Journal and what is the Article Processing Charge (APC)?

Rare Disease and Orphan Drugs Journal is published by OAE PUBLISHING INC. The estimated Article Processing Charge (APC) is approximately $2,792 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Rare Disease and Orphan Drugs Journal?

The official ISO-4 abbreviation of Rare Disease and Orphan Drugs Journal is "RARE DIS ORPH DRUG J". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS ESCI Q3Scopus Q3SCImago #14,604Hybrid

Rare Disease and Orphan Drugs Journal

Abbreviation (ISO):RARE DIS ORPH DRUG J

•

Identifier (ISSN):2771-2893(Online)

•

Publisher:OAE PUBLISHING INC

Clarivate JCR Index Advisory: Active (ESCI)

Compare

Clarivate IF (2026)

1.9↑ +1.9

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend

Clarivate IF trend for Rare Disease and Orphan Drugs Journal

WoS Q3

Annual Impact Factor Metric

Current (2026):1.9

Scopus SJR & RankScopus Q3

0.385

#14,604

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

7 papers with at least that number of citations each

WoS: ESCIQ3

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

N/Aarticles/year

74.12% Gold OA•N/A Original Research

Aims & Scope

Rare Disease and Orphan Drugs Journal (abbr: RARE DIS ORPH DRUG J) is a peer-reviewed international scholarly journal in the field of GENETICS & HEREDITY, published by OAE PUBLISHING INC. The periodical holds a Journal Impact Factor (JIF) of 1.90, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.385 (Q3), an H-index of 7.

Primary Research Areas

Genetics & Heredity Pharmacology & Pharmacy

SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

GENETICS & HEREDITY

Rank140/192

IndexESCI

JCRESCI2026

PHARMACOLOGY & PHARMACY

Rank253/356

IndexESCI

JCIESCI2026

GENETICS & HEREDITY

Rank169/192

IndexESCI

JCIESCI2026

PHARMACOLOGY & PHARMACY

Rank296/356

IndexESCI

Category	Index	Rank	Quartile
GENETICS & HEREDITY	JCRESCI	140/192	Q3
PHARMACOLOGY & PHARMACY	JCRESCI	253/356	Q3
GENETICS & HEREDITY	JCIESCI	169/192	Q4
PHARMACOLOGY & PHARMACY	JCIESCI	296/356	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

1 year

2026Latest

IF1.9

Articles / Year—

Total Citations—

Year	Impact Factor	Articles / Year	Total Citations
2026	1.9	—	—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,604Scopus Q3SCImago Profile

Scopus Coverage:2022-2025

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q3

0.385

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.73

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,792 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations132

3-Year Documents74

Citable Documents68

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Genetics (clinical)Q3

Internal MedicineQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Academic Intelligence Overview & Context

ImpaQ Analysis

The publication maintains comprehensive double-blind or single-blind international peer-review standards. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,792 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.